GEOHealth Hub Peru: Building U.S. Research Capacity Through International Environmental Health Science on Air Pollution, Cardiorespiratory Disease, and Alzheimer’s Disease
Official title: GEOHealth Hub Peru: Building U.S. Research Capacity Through International Environmental Health Science on Air Pollution, Cardiorespiratory Disease, and Alzheimer’s Disease (Research Training U2R)
Funded at Emory University · NIH-11545053 · Data updated 2026-11-12
A training-focused NIH grant partners with Peru to build environmental health research capacity, studying how air pollution affects heart and brain diseases to inform U.S. health standards.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | September 28, 2015 |
| Project end | February 28, 2027 |
| Funding year | 2026 |
| Award (this year) | $122,756 |
| NIH project number | 3U2RTW010114-10S1 |
| Project ID | NIH-11545053 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include individuals living in high-pollution or high-altitude regions or patients with cardiorespiratory conditions or Alzheimer’s-related symptoms who may be enrolled in related future studies or benefit from improved public health practices.
✕Less likely to help
Patients not engaged in environmental exposure contexts or not connected to cardiorespiratory or Alzheimer's disease networks may see limited direct benefit.
What this research studies
This grant supports a collaborative training center in Lima, Peru, with regional partners to study how ambient air pollution influences heart and lung health and Alzheimer’s disease. It focuses on developing researchers who can conduct long-term atmospheric and health studies in diverse altitude and pollution settings. The program emphasizes cross-national collaboration, mentorship, and the creation of longitudinal cohorts and infrastructure that will benefit U.S. institutions as well. Participants may include clinicians, scientists, and trainees who will contribute to translational research linking air quality to disease outcomes.
Why it matters
Potential benefit: If successful, patients could benefit from cleaner air policies, improved clinical guidelines, and new research-trained clinicians contributing to better prevention and management of cardiorespiratory and neurodegenerative diseases.
How similar studies have gone: Past collaborations have trained hundreds of investigators and produced multiple co-authored publications, indicating productive international training models, though direct outcomes on Alzheimer’s-specific mechanisms require further study.
Where this research is happening
-
Emory University
Atlanta, United States Active
Researchers
- Principal investigator: Steenland, Nelson K — Emory University
- Study coordinator: Steenland, Nelson K
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.